Crossmark

Intravital three-dimensional bioprinting

Crossref DOI link: https://doi.org/10.1038/s41551-020-0568-z

Published Online: 2020-06-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Urciuolo, Anna https://orcid.org/0000-0001-7571-9747
Poli, Ilaria https://orcid.org/0000-0003-2275-8376
Brandolino, Luca

Raffa, Paolo https://orcid.org/0000-0003-0370-6108
Scattolini, Valentina

Laterza, Cecilia https://orcid.org/0000-0002-3964-3375
Giobbe, Giovanni G. https://orcid.org/0000-0001-6958-7303
Zambaiti, Elisa

Selmin, Giulia https://orcid.org/0000-0001-9234-5281
Magnussen, Michael https://orcid.org/0000-0003-3054-9806
Brigo, Laura https://orcid.org/0000-0001-6703-3921
De Coppi, Paolo https://orcid.org/0000-0002-1659-0207
Salmaso, Stefano https://orcid.org/0000-0003-4705-5909
Giomo, Monica https://orcid.org/0000-0002-7690-1054
Elvassore, Nicola https://orcid.org/0000-0002-7029-6287
License Information

Text and Data Mining valid from 2020-06-22

Version of Record valid from 2020-06-22
More Information

Article History

Received: 22 July 2019

Accepted: 8 May 2020

First Online: 22 June 2020

Competing interests

: N.E. has an equity stake in ONYEL Biotech s.r.l. A.U. and N.E. are submitting a patent for the intravital 3D bioprinting (provisional patent number 102020000008779).